$0.5485
-0.0231-4.04%
Últ. Act.: Nov 2, 7:34 AM
Mira Pharmaceuticals (MIRA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | $-0.05 | $-0.07 | $-0.09 |
| Actual | $-0.03 | $-0.03 | $0.10 | $-1.18 |
| Surprise | — | +40.0% | +242.9% | -1211.1% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.03 | $-0.03 |
| Revenue | ||
| Consensus | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q1 | May 14, 2026 | $-0.03 | $-0.05 | 40.0 % |
| Q4 | Mar 31, 2026 | $0.10 | $-0.07 | 242.9 % |
| Q3 | Nov 13, 2025 | $-1.18 | $-0.09 | -1211.1 % |
| Q2 | Aug 14, 2025 | $-0.09 | $-0.12 | 25.0 % |